These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7082647)

  • 41. Ligand-receptor dissociation: a potential mechanism for the attenuation of estrogen action in the juvenile rabbit uterus.
    Chilton BS; Williams ND; Cobb AD; Leavitt WW
    Endocrinology; 1987 Feb; 120(2):750-7. PubMed ID: 3803303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The thermolability of rat uterine cytosol estrogen receptors: basis for a novel cytosol exchange-denaturation assay.
    Woosley JT; Muldoon TG
    J Steroid Biochem; 1979 Aug; 11(2):1065-71. PubMed ID: 502549
    [No Abstract]   [Full Text] [Related]  

  • 43. Determination of cytosol and nuclear estradiol-binding sites in fetal guinea pig uterus by [3H]estradiol exchange.
    Sumida C; Pasqualini JR
    Endocrinology; 1979 Aug; 105(2):406-13. PubMed ID: 456319
    [No Abstract]   [Full Text] [Related]  

  • 44. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response.
    Markaverich BM; Clark JH
    Endocrinology; 1979 Dec; 105(6):1458-62. PubMed ID: 574077
    [No Abstract]   [Full Text] [Related]  

  • 45. Accelerated dissociation of estrogen receptor--ligand complexes by estradiol. Evidence for negative cooperativity of binding.
    Rosner AL; Schwartz AM; Bray CL; Burstein NA
    Arch Biochem Biophys; 1979 Nov; 198(1):153-63. PubMed ID: 507836
    [No Abstract]   [Full Text] [Related]  

  • 46. Electrophoretic analysis of the estrogen receptor. Relationship of multiple receptor forms to the molybdate-stabilized form.
    Skipper JK; Davidson FI; Hamilton TH
    J Biol Chem; 1985 Nov; 260(27):14636-41. PubMed ID: 4055793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antagonism to estradiol in the mouse: reduced entry of receptors complexed with 4-hydroxytamoxifen into a Mg2+-soluble chromatin fraction.
    Pavlik EJ; van Nagell JR; Nelson K; Gallion H; Donaldson ES; Kenady DE; Baranowska-Kortylewicz J
    Endocrinology; 1986 May; 118(5):1924-34. PubMed ID: 2422013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of estradiol--receptor complex by ATP in vitro.
    Moudgil VK; Eessalu TE
    FEBS Lett; 1980 Dec; 122(2):189-92. PubMed ID: 7202708
    [No Abstract]   [Full Text] [Related]  

  • 49. Properties of the estrogen receptors contained in the MtTF4 tumor whose growth is inhibited by estradiol: 17 beta-estradiol, 17 alpha-estradiol and DNA bindings.
    Albaladejo V; Pharaboz MO; Morel Y; Andre J
    J Steroid Biochem; 1986 Jul; 25(1):29-36. PubMed ID: 3747513
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progesterone regulation of estrogen receptor in the hamster uterus during the estrous cycle.
    Evans RW; Chen TJ; Hendry WJ; Leavitt WW
    Endocrinology; 1980 Aug; 107(2):383-90. PubMed ID: 7190093
    [No Abstract]   [Full Text] [Related]  

  • 51. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estradiol binding and phosphatase activity in the uterus after castration and chronic diabetes: effect of molybdate and estrogen replacement.
    Fridman O; Moses D; De Nicola AF
    Acta Physiol Pharmacol Latinoam; 1985; 35(2):193-203. PubMed ID: 3008502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Purification of the molybdate-stabilized 9-10 S estradiol receptor from calf uterus.
    Atrache V; Ratajczak T; Senafi S; Hähnel R
    J Biol Chem; 1985 May; 260(10):5936-41. PubMed ID: 3997805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparative analysis of the interaction of various estrogens with the estrogen-receptor system of the uterus].
    Fanchenko ND; Alekseeva ML; Minina LS; Novikov EA; Khel'mun DK
    Biokhimiia; 1985 Nov; 50(11):1853-8. PubMed ID: 4063405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of specific high affinity sites for the estradiol receptor in the erythrocyte cytoskeleton.
    Puca GA; Sica V
    Biochem Biophys Res Commun; 1981 Nov; 103(2):682-9. PubMed ID: 7332563
    [No Abstract]   [Full Text] [Related]  

  • 56. Specific binding of estrogen and estrogen-receptor complex by microsomes from estrogen-responsive tissues of the rat.
    Watson GH; Muldoon TG
    Endocrinology; 1985 Oct; 117(4):1341-9. PubMed ID: 4029080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen action in the mouse uterus: characterization of the cytosol and nuclear receptor systems.
    Korach KS
    Endocrinology; 1979 May; 104(5):1324-32. PubMed ID: 436778
    [No Abstract]   [Full Text] [Related]  

  • 58. Binding of the estradiol receptor from calf uterus to the chromatin: active forms.
    Sala-Trepat JM; Vallet-Strouvé C
    Biochim Biophys Acta; 1974 Nov; 371(1):186-202. PubMed ID: 4371853
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of arginyl residues in estrogen receptor activation and transformation.
    Müller RE; Mrabet NT; Traish AM; Wotiz HH
    J Biol Chem; 1983 Oct; 258(19):11582-9. PubMed ID: 6619130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uterine receptor-estradiol complexes and their interaction with nuclear binding sites.
    Clark JH; Eriksson HA; Hardin JW
    J Steroid Biochem; 1976; 7(11-12):1039-43. PubMed ID: 1025347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.